TruNativ Secures $30 Million Funding From OrbiMed
The newly raised capital will be deployed across strategic priorities, a nationwide distribution expansion across D2C, quick commerce, modern trade, pharmacy and other retail channels.
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
TruNativ, a science-backed everyday nutrition company, today announced the close of its funding round of ~$30M, led by OrbiMed, a healthcare investment firm. The Series B funding round comprised both primary investment and the sale of secondary shares of early investors. The investment marks a significant milestone in TruNativ’s journey to build India’s most trusted nutrition platform and strengthen access to clean, science-backed nutrition solutions for consumers across the country.
The newly raised capital will be deployed across strategic priorities, a nationwide distribution expansion across D2C, quick commerce, modern trade, pharmacy and other retail channels; and the continued expansion of TruNativ’s B2B2C ingredient business, which currently powers nutrition solutions for several leading consumer brands in India.
Pranav Malhotra, Co-Founder & CEO, TruNativ, said: “India’s nutrition transformation is not a trend, it is a reckoning. For decades, Indian consumers have been underserved: overexposed to sugar, protein deficiency, and dependent on products that promise health but deliver compromise. We built TruNativ to fix that for every household, not just the health-conscious few. OrbiMed’s investment signals that preventive nutrition is no longer a wellness trend — it is a healthcare imperative. Our commitment is to make India a global leader in nutrition innovation, not just a consumer of it.”
OrbiMed’s investment reflects growing confidence in India’s nutrition and preventive healthcare ecosystem. As consumers increasingly prioritize healthier lifestyles and proactive wellness, demand for clean-label, science-backed nutrition solutions continues to accelerate. Founded by mother-son duo Pranav Malhotra and Mamta Malhotra in 2019 in Mumbai, TruNativ has grown from a single sugar-replacement product into a clean-label nutrition platform spanning sugar alternatives, protein, gut health, and wellness.
TruNativ, a science-backed everyday nutrition company, today announced the close of its funding round of ~$30M, led by OrbiMed, a healthcare investment firm. The Series B funding round comprised both primary investment and the sale of secondary shares of early investors. The investment marks a significant milestone in TruNativ’s journey to build India’s most trusted nutrition platform and strengthen access to clean, science-backed nutrition solutions for consumers across the country.
The newly raised capital will be deployed across strategic priorities, a nationwide distribution expansion across D2C, quick commerce, modern trade, pharmacy and other retail channels; and the continued expansion of TruNativ’s B2B2C ingredient business, which currently powers nutrition solutions for several leading consumer brands in India.
Pranav Malhotra, Co-Founder & CEO, TruNativ, said: “India’s nutrition transformation is not a trend, it is a reckoning. For decades, Indian consumers have been underserved: overexposed to sugar, protein deficiency, and dependent on products that promise health but deliver compromise. We built TruNativ to fix that for every household, not just the health-conscious few. OrbiMed’s investment signals that preventive nutrition is no longer a wellness trend — it is a healthcare imperative. Our commitment is to make India a global leader in nutrition innovation, not just a consumer of it.”
